National Comprehensive Cancer Network

About NCCN

NCCN News

NCCN welcomes the opportunity to work with reporters on all cancer-related topics. NCCN offers members of the media access to scientific and medical experts, news releases, background research, and much more. We can also help connect press with investigators and clinicians who can discuss research, treatment and issues related to cancer through coordination with media contacts at NCCN Member Institutions.

For news, interviews, photo requests or the most current information and resources available, please contact:

Note: NCCN neither reviews nor approves press releases announcing the inclusion of tests, agents, and/or therapies listed within the NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®). For any additional commercial use of NCCN Content in promotional and educational materials, NCCN requires a license and review of content.

Newsroom

Press kits, media advisories, and information on upcoming events.

Press Releases

• NCCN: What People with Cancer and their Caregivers Need to Know about CAR T-Cell Therapy  (07/01/2020)
• How to Recognize Side-Effects from Immunotherapy? New NCCN Guidelines for Patients can Help  (06/29/2020)
• The Charitable Foundation “Leukemia Foundation”, supported by the company Janssen Russia, a pharmaceutical product sub-division of Johnson & Johnson LLC, has provided the first Russian translation of the NCCN Guidelines for Patients on treating multiple myeloma  (06/26/2020)
• NCCN Works to Improve Global Cancer Care for Children with Newly Translated Recommendations  (06/16/2020)

View more >

Health Care Policy News

View more >

NCCN eBulletin Newsletter

June 29, 2020 | Volume 12 Issue 135

• NCCN Flash Updates: NCCN Templates^® Updated for Esophageal and Esophagogastric Junction Cancers and NCCN Guidelines with Evidence Blocks™ Updated for Non-Small Cell Lung Cancer
• New Resource Shares Information for Patients and Caregivers on How to Manage Adverse Events from Immune Checkpoint Inhibitors
• 2020-2021 Series Starting! Monthly Oncology Tumor Boards: A Multidisciplinary Approach to Individualized Patient Care
• Recordings Now Available! NCCN Best Practices Webinar Series: Creative Strategies Implemented during COVID-19 that will Impact the Future of Cancer Care

June 22, 2020 | Volume 12 Issue 13

• NCCN Flash Updates: NCCN Guidelines^® Updated for Hepatobiliary Cancer
• Now Available! Free Pocket-Sized NCCN Guidelines for Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma
• NCCN Works to Improve Global Cancer Care for Children with Newly Translated Recommendations
• Earn CE Credits and Learn More About the Behind-the-Scenes Views into the NCCN Guidelines Panel Discussions that Lead to Important Updates

View more >

NCCN in the News

• Clinton Health Access Initiative: New Agreements to Lower Prices and Increase Access to Lifesaving Cancer Treatment in Sub-Saharan   (06/29/2020)
• STAT: Treatment barriers create racial disparities in cancer care. They need to come down   (06/24/2020)
• Targeted Oncology: Doctors Debate: Is Chemoimmunotherapy or Small Molecule Inhibition Most Optimal for Frontline Treatment of CLL?   (06/18/2020)
• Journal of Clinical Pathways: Overview of the Updated NCCN Guidelines on Ovarian Cancer  (06/17/2020)

View more >

NCCN Member Institutions in the News

• MSK Researchers Find that Common Cancer Treatments Don’t Worsen Coronavirus Infection   (06/24/2020)
• CU Cancer Center Study Tackles Racial and Socioeconomic Disparities in Patients with Lung Cancer   (06/24/2020)
• Inherited Mutation Found Among Brazilians Increases Cancer Risk   (06/24/2020)
• Biomarker Test Highly Accurate in Detecting Early Kidney Cancer   (06/22/2020)

View more >